BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11938024)

  • 1. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients.
    Kesavulu MM; Kameswararao B; Apparao Ch; Kumar EG; Harinarayan CV
    Diabetes Metab; 2002 Feb; 28(1):20-6. PubMed ID: 11938024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients.
    Peuchant E; Delmas-Beauvieux MC; Couchouron A; Dubourg L; Thomas MJ; Perromat A; Clerc M; Gin H
    Diabetes Care; 1997 Feb; 20(2):202-7. PubMed ID: 9118775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
    Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
    Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating efficacy of Rebaudioside A, a diterpenoid on antioxidant and circulatory lipids in experimental diabetic rats.
    Saravanan R; Ramachandran V
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):472-483. PubMed ID: 23792234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.
    Evereklioglu C; Er H; Doganay S; Cekmen M; Turkoz Y; Otlu B; Ozerol E
    Doc Ophthalmol; 2003 Mar; 106(2):129-36. PubMed ID: 12678277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria.
    Yadav D; Mishra M; Joseph AZ; Subramani SK; Mahajan S; Singh N; Bisen PS; Prasad GB
    Obes Res Clin Pract; 2015; 9(2):158-67. PubMed ID: 25890429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia.
    Bouzidi N; Mekki K; Boukaddoum A; Dida N; Kaddous A; Bouchenak M
    J Ren Nutr; 2010 Sep; 20(5):321-8. PubMed ID: 20303788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
    Yessoufou A; Soulaimann N; Merzouk SA; Moutairou K; Ahissou H; Prost J; Simonin AM; Merzouk H; Hichami A; Khan NA
    Int J Obes (Lond); 2006 May; 30(5):739-50. PubMed ID: 16418759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats.
    Ozansoy G; Akin B; Aktan F; Karasu C
    Mol Cell Biochem; 2001 Jan; 216(1-2):59-63. PubMed ID: 11216864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.
    Whiting PH; Kalansooriya A; Holbrook I; Haddad F; Jennings PE
    Br J Biomed Sci; 2008; 65(2):71-4. PubMed ID: 19055108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.
    Turk HM; Sevinc A; Camci C; Cigli A; Buyukberber S; Savli H; Bayraktar N
    Acta Diabetol; 2002 Sep; 39(3):117-22. PubMed ID: 12357295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice.
    Bhattacharya A; Lawrence RA; Krishnan A; Zaman K; Sun D; Fernandes G
    J Am Coll Nutr; 2003 Oct; 22(5):388-99. PubMed ID: 14559931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant status and lipid peroxidation in type II diabetes mellitus.
    Memisoğullari R; Taysi S; Bakan E; Capoglu I
    Cell Biochem Funct; 2003 Sep; 21(3):291-6. PubMed ID: 12910484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity.
    Bandeira Sde M; Guedes Gda S; da Fonseca LJ; Pires AS; Gelain DP; Moreira JC; Rabelo LA; Vasconcelos SM; Goulart MO
    Oxid Med Cell Longev; 2012; 2012():819310. PubMed ID: 23259029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic effects of nerolidol through promoting insulin receptor signaling in high-fat diet and low dose streptozotocin-induced type 2 diabetic rats.
    Jiang N; Zhang Y
    Hum Exp Toxicol; 2022; 41():9603271221126487. PubMed ID: 36169646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamins A, E, C and omega-3 fatty acids supplementation on the level of catalase and superoxide dismutase activities in streptozotocin-induced diabetic rats.
    Tabei SM; Fakher S; Djalali M; Javanbakht MH; Zarei M; Derakhshanian H; Sadeghi MR; Mostafavi E; Kargar F
    Bratisl Lek Listy; 2015; 116(2):115-8. PubMed ID: 25665478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.